Who Owns iBio Stock?
NASDAQ: IBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 0.98 +6.52%
Ownership breakdown
- Held by institutions
- 55.40%
- Held by insiders
- 1.32%
- Institutional holders
- 67
- Institutions 55.4%
- Insiders 1.3%
- Public and other 43.3%
Who owns iBio stock?
Institutional investors own about 55.4% of iBio's shares, spread across 67 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 1.32% of IBIO.
The largest institutional holders are Affinity Asset Advisors, Llc (6.23%), Cormorant Asset Management, LP (5.55%) and SilverArc Capital Management, LLC (5.47%). Together, the top 10 institutions control 37.9% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their IBIO positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IBIO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Affinity Asset Advisors, Llc | 4.01M | 6.23% | +29.0% |
| Cormorant Asset Management, LP | 3.57M | 5.55% | +100.0% |
| SilverArc Capital Management, LLC | 3.52M | 5.47% | +1457.7% |
| Vestal Point Capital, LP | 2.60M | 4.04% | +100.0% |
| Vanguard Capital Management LLC | 2.10M | 3.26% | +92.8% |
| Frazier Life Sciences Management, L.P. | 1.95M | 3.04% | 0.0% |
| Ensign Peak Advisors, Inc | 1.83M | 2.85% | +100.0% |
| Woodline Partners LP | 1.78M | 2.76% | +100.0% |
| Millennium Management Llc | 1.65M | 2.57% | +6.6% |
| Citadel Advisors Llc | 1.38M | 2.15% | +44.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IBIO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.47M | 2.28% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 582.07K | 0.91% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 257.76K | 0.40% |
| iShares Trust-iShares Micro-Cap ETF | 103.15K | 0.16% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 75.30K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 74.56K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 31.08K | 0.05% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 29.59K | 0.05% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 20.66K | 0.03% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 6.97K | 0.01% |
Frequently asked questions
Who is the largest shareholder of iBio?
Affinity Asset Advisors, Llc is the largest institutional shareholder of IBIO, owning 6.23% of shares outstanding (4.01M shares) as of its latest 13F filing.
What percentage of iBio is owned by institutions?
Institutions own about 55.4% of IBIO shares and 56.1% of the public float.
How much of iBio do insiders own?
Insiders, such as officers and directors, own about 1.32% of IBIO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.